Stock Events

Stock Events

Athersys 

$0.000001
47
-$0.00-99% 17:54 Today

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.000001
Volume
16,426
Avg. Volume
0
Mkt Cap
61.72
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q4 0
Q1 2024
Q2 2024
Q3 2024
-0.2
-0.19
-0.17
-0.16
Expected EPS
-0.16
Actual EPS
N/A

Financials

-1,362.14%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
5.33MRevenue
-72.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATHXQ. It's not an investment recommendation.
Main Street Capital
2
MAIN
JPMorgan Chase
2
JPM
Arbor Realty Trust
2
ABR
Global X Nasdaq 100 Covered Call UCITS USD Dis
2
QYLP.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mesoblast
MESO
Mkt Cap2.02B
Mesoblast Limited focuses on the development of regenerative medicine, similar to Athersys' work in stem cell therapies.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap11.92M
Brainstorm Cell Therapeutics works on stem cell-based treatments for neurodegenerative diseases, competing in the broader regenerative medicine space.
Vericel
VCEL
Mkt Cap2.26B
Vericel Corporation specializes in autologous cell therapies for markets that Athersys is also targeting, including treatments for various medical conditions.
Biolife Solutions
BLFS
Mkt Cap1.72B
BioLife Solutions provides biopreservation media and services for cells, which are critical in the cell therapy market where Athersys operates.
Mimedx Group
MDXG
Mkt Cap622.4M
MiMedx Group, Inc. offers regenerative biomaterials and bioimplants, which are part of the broader regenerative medical field.
Fate Therapeutics
FATE
Mkt Cap307.94M
Fate Therapeutics is involved in the development of programmed cellular immunotherapies, competing in the innovative treatment sector like Athersys.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics AG focuses on gene editing, a cutting-edge technology in the therapeutic area that could intersect with Athersys' interests in advanced therapies.

About

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliates on January 5, 2024.
Show more...
CEO
Ms. Z. Kasey Rosado
Employees
24
Country
United States
ISIN
US04744L2051
WKN
000A3DR6K

Listings

MU
DE
4LSA.MU
OTC Link
US
ATHXQ

0 Comments

Share your thoughts

FAQ

What is Athersys stock price today?▼
The current price of ATHXQ is $0.00 USD — it has decreased by -99% in the past 24 hours. Watch Athersys stock price performance more closely on the chart.
What is Athersys stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Athersys stocks are traded under the ticker ATHXQ.
Is Athersys stock price growing?▼
ATHXQ stock has fallen by -99% compared to the previous week, the month change is a -99% fall, over the last year Athersys has showed a -99% decrease.
What is Athersys market cap?▼
Today Athersys has the market capitalization of 61.72
What is Athersys revenue for the last year?▼
Athersys revenue for the last year amounts to 5.33M USD.
What is Athersys net income for the last year?▼
ATHXQ net income for the last year is -72.53M USD.
How many employees does Athersys have?▼
As of August 19, 2026, the company has 24 employees.
In which sector is Athersys located?▼
Athersys operates in the Health & Wellness sector.
When did Athersys complete a stock split?▼
Athersys has not had any recent stock splits.
Where is Athersys headquartered?▼
Athersys is headquartered in Cleveland, United States.